EBV-associated plasmablastic lymphoma in a patient with Crohn's disease after adalimumab treatment.
Li
L
Liu
Aline
A
Charabaty
Metin
M
Ozdemirli
D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D020031:Epstein-Barr Virus Infections / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis / Q000821:virology
D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000068879:Adalimumab